These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20012029)

  • 1. Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs.
    António N; Fernandes R; Rodriguez-Losada N; Jiménez-Navarro MF; Paiva A; de Teresa Galván E; Gonçalves L; Ribeiro CF; Providência LA
    Eur J Clin Pharmacol; 2010 Mar; 66(3):219-30. PubMed ID: 20012029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial progenitor cells in cardiovascular disorders.
    Shantsila E; Watson T; Lip GY
    J Am Coll Cardiol; 2007 Feb; 49(7):741-52. PubMed ID: 17306702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cells: markers of vascular reparative capacity.
    Povsic TJ; Goldschmidt-Clermont PJ
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):199-213. PubMed ID: 19124422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis.
    Hoenig MR; Bianchi C; Sellke FW
    Curr Drug Targets; 2008 May; 9(5):422-35. PubMed ID: 18473772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endothelial progenitor cells in cardiovascular disorders.
    Geft D; Schwartzenberg S; George J
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1115-21. PubMed ID: 18793114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial progenitor cells: therapeutic target for cardiovascular diseases.
    Umemura T; Higashi Y
    J Pharmacol Sci; 2008 Sep; 108(1):1-6. PubMed ID: 18776710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches to improve endothelial repair mechanisms.
    Besler C; Doerries C; Giannotti G; Lüscher TF; Landmesser U
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1071-82. PubMed ID: 18793110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors.
    Balbarini A; Barsotti MC; Di Stefano R; Leone A; Santoni T
    Curr Pharm Des; 2007; 13(16):1699-713. PubMed ID: 17584100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of insulin resistance on endothelial function, progenitor cells and repair.
    Cubbon RM; Rajwani A; Wheatcroft SB
    Diab Vasc Dis Res; 2007 Jun; 4(2):103-11. PubMed ID: 17654443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
    Kawamoto A; Asahara T
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular repair by endothelial progenitor cells.
    Zampetaki A; Kirton JP; Xu Q
    Cardiovasc Res; 2008 Jun; 78(3):413-21. PubMed ID: 18349136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
    Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells.
    Reynolds JA; Robertson AC; Bruce IN; Alexander MY
    Pharmacol Ther; 2014 May; 142(2):231-43. PubMed ID: 24333265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPCs and pathological angiogenesis: when good cells go bad.
    Li Calzi S; Neu MB; Shaw LC; Kielczewski JL; Moldovan NI; Grant MB
    Microvasc Res; 2010 May; 79(3):207-16. PubMed ID: 20188747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial progenitor cells as a new agent contributing to vascular repair.
    Miller-Kasprzak E; Jagodziński PP
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2.
    Wu Y; Dai J; Schmuckler NG; Bakdash N; Yoder MC; Overall CM; Colman RW
    J Thromb Haemost; 2010 Jan; 8(1):185-93. PubMed ID: 19874467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct phenotypes and regenerative potentials of early endothelial progenitor cells and outgrowth endothelial progenitor cells derived from umbilical cord blood.
    Reagan J; Foo T; Tracy Watson J; Jin W; Moed BR; Zhang Z
    J Tissue Eng Regen Med; 2011 Aug; 5(8):620-8. PubMed ID: 21774085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of endothelial progenitor cells and statins in endothelial function: a review.
    Gómez-Cerezo JF; Pagán-Muñoz B; López-Rodríguez M; Estébanez-Muñoz M; Barbado-Hernández FJ
    Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):265-72. PubMed ID: 17979688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration.
    Iwaguro H; Yamaguchi J; Kalka C; Murasawa S; Masuda H; Hayashi S; Silver M; Li T; Isner JM; Asahara T
    Circulation; 2002 Feb; 105(6):732-8. PubMed ID: 11839630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.